Authors’ Disclosures
MapKure, Cancer
CANCER
K.M. Campbell reports personal fees from Flagship Labs 81, PACT Pharma, Tango Therapeutics, and Rare Cancer Research Foundation, personal fees and other from Geneoscopy LLC outside the submitted work. T.S. Nowicki reports personal fees from Allogene Therapeutics, PACT Pharma, and Adaptive Biotechnologies outside the submitted work. A. Ribas reports personal fees from Amgen, BMS during the conduct of the study; personal fees from 4C Biomed, Advaxis, Amgen, Appia, Apricity, Arcus, Chugai, Compugen, CytomX, Five Prime, Genentech, Highlight, ImaginAb, Isoplexis, Kalthera-Immpact Bio, Kite-Gilead Lutris, MapKure, Merck, Merus, Novartis, PACT Pharma, RAPT, Rgenix, Roche, Sanofi, Synthekine, Tango, Vedanta outside the submitted work. No disclosures were reported by the other authors.